Samkaksh Impex Private Limited
About Samkaksh Impex Private Limited
Data last updated:
Samkaksh Impex Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 January 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2003PTC118312.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pallavi Jain and Vinod Kumar Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 165 1st Floor Block Gd Landmark, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.55 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹14.58 Lakh (net margin 74.6%) and EBITDA of ₹18.01 Lakh (EBITDA margin 92.1%). Revenue has grown at a compounded annual rate (CAGR) of 240% over five years.
As per MCA filings, the company has open charges of ₹2.49 Cr and satisfied charges of ₹2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Samkaksh Impex Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 165 1st Floor Block Gd Landmark, New Delhi, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Samkaksh Impex Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Samkaksh Impex Private Limited
FY 2025 filings availableSamkaksh Impex Private Limited reported revenue of ₹19.55 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 240% over five years, including 8% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 92.1% | ||||
| Net Profit Margin | 74.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Samkaksh Impex Private Limited, buy the company report.
Board of directors of Samkaksh Impex Private Limited
Samkaksh Impex has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pallavi Jain | Director | 12 Nov 2021 | 4 Years 11 Months | Current |
| Vinod Kumar Jain | Director | 12 Nov 2021 | 4 Years 11 Months | Current |
| Manju Jain | Director | 12 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Samkaksh Impex Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ammolite Meditech Private Limited | ₹19.83 Lakh (FY 2019) | -57.0% | Raipur, Chhattisgarh, India | |||
| Drishtideep Diagnostics & Research Private Limited | ₹19.76 Lakh (FY 2018) | 30.0% | Kolkata, West Bengal, India | |||
| Cadinova Biotech Private Limited | ₹19.75 Lakh (FY 2022) | 77.0% | Pune, Maharashtra, India | |||
| Dacious Pharma Private Limited | ₹19.75 Lakh (FY 2016) | -57.0% | Mumbai, Maharashtra, India | |||
| Orichem Laboratories Private Limited | ₹19.63 Lakh (FY 2025) | 70.0% | Chinchwad, Maharashtra, India | |||
| Samkaksh Impex Private Limitedthis company | ₹19.55 Lakh (FY 2025) | ₹14.58 Lakh | 74.6% | 8.0% | New Delhi, Delhi, India | |
| Astroma Lifesciences Private Limited | ₹19.55 Lakh (FY 2018) | 124.0% | Lucknow, Uttar Pradesh, India | |||
| Ivy Nelson Pharmaceuticals Private Limited | ₹19.48 Lakh (FY 2019) | -14.0% | Piplod, Gujarat, India | |||
| Yashan Healthcare Private Limited | ₹19.47 Lakh (FY 2022) | 2243.0% | Pune, Maharashtra, India | |||
| Neo Meditech Services Private Limited | ₹19.46 Lakh (FY 2025) | 451.0% | Pune, Maharashtra, India | |||
| Heartkind Pharmaceuticals Private Limited | ₹19.43 Lakh (FY 2021) | Jaipur, Rajasthan, India |
To see the full peer comparison of Samkaksh Impex Private Limited, buy the company report.
Auditor
Samkaksh Impex Private Limited is audited by P N ARORA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P N ARORA & CO | FY 2019 | 008883C |
Shareholding
The shareholding of Samkaksh Impex Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Samkaksh Impex Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Apr 2023 | 100701253 | Others | ₹2.49 Cr | Open | |
| 11 Feb 2009 | 10148305 | Indian Overseas Bank | ₹2 Cr | Satisfied |
To see the full charge records of Samkaksh Impex Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Samkaksh Impex Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Samkaksh Impex Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Samkaksh Impex Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Samkaksh Impex Private Limited has 8 board changes on record since 2008: 3 appointments and 5 cessations. The latest: Parminder Saini ceased to be Director on 09 Mar 2022.
3 earlier events are in the company report.
Frequently asked questions
Samkaksh Impex is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 January 2003 (23+ years old) and is registered under CIN U51397DL2003PTC118312.
Samkaksh Impex has 3 current directors:
- Pallavi Jain - Director
- Vinod Kumar Jain - Director
- Manju Jain - Director
The latest financial statements of Samkaksh Impex on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Samkaksh Impex is U51397DL2003PTC118312. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Samkaksh Impex was incorporated on 06 January 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Samkaksh Impex by revenue are Ammolite Meditech Private Limited, Drishtideep Diagnostics & Research Private Limited, Cadinova Biotech Private Limited, Dacious Pharma Private Limited, Orichem Laboratories Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Parminder Saini ceased to be Director on 09 Mar 2022. Vishwa Deepak Chauhan ceased to be Director on 09 Mar 2022. Manju Jain was appointed as Director on 12 Nov 2021. Samkaksh Impex has 8 board changes on record in total.
The registered office of Samkaksh Impex is at House No. 165 1st Floor Block Gd Landmark, New Delhi, Delhi, India – 110034.
Samkaksh Impex operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Samkaksh Impex has open charges of ₹2.49 Cr and satisfied charges of ₹2 Cr as per latest MCA filings.
The compliance status of Samkaksh Impex is compliant as of 09 September 2026. The company is actively filing with the Registrar of Companies.